Resultados da pesquisa - Restelli U

Financial and feasibility implications of the treatment of hepatitis C virus in Italy: scenarios and perspectives Por Croce D, Bonfanti M, Restelli U

Obter o texto integral

Co-Design as Enabling Factor for Patient-Centred Healthcare: A Bibliometric Literature Review Por Silvola S, Restelli U, Bonfanti M, Croce D

Obter o texto integral

Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem... Por Restelli U, Croce D, Pacelli V, Ciceri F, Girmenia C

Obter o texto integral

Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy start... Por Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, Croce D

Obter o texto integral

Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy start... Por Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, Croce D

Obter o texto integral

Update of the budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies... Por Restelli U, Fabbiani M, Di Giambenedetto S, Nappi C, Croce D

Obter o texto integral

Protocol Implementation for Normothermia in Surgery Settings in Italy: Budget-Impact Analysis Por Monzani R, Barbera G, Restelli U, Galeone C, Petrini F

Obter o texto integral

Health Technology Assessment for Fast-Track Elective Knee and Hip Arthroplasty in a High-Volume Orthopaedic Hospital in Italy Por Restelli U, Vitale J, Croce E, Bernareggi S, Guida S, Silvola S, Banfi G, Zagra L

Obter o texto integral

Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatm... Por Restelli U, Rizzardini G, Antinori A, Lazzarin A, Bonfanti M, Bonfanti P, Croce D

Obter o texto integral

Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study [Corrigendum] Por Restelli U, Ceresoli GL, Croce D, Evangelista L, Maffioli LS, Gianoncelli L, Bombardieri E

Obter o texto integral

Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study Por Restelli U, Ceresoli GL, Croce D, Evangelista L, Maffioli LS, Gianoncelli L, Bombardieri E

Obter o texto integral

Cost of human immunodeficiency virus infection in Italy, 2007–2009: effective and expensive, are the new drugs worthwhile? Por Rizzardini G, Restelli U, Bonfanti P, Porazzi E, Ricci E, Foglia E, Carenzi L, Croce D

Obter o texto integral

Monocentric Analysis of the Effectiveness and Financial Consequences of the Use of Lenograstim versus Filgrastim for Mobilization of Peripheral Blood Progenitor Cells in Patients w... Por Restelli U, Croce D, Bonizzoni E, Marzanatti M, Andreini A, Sorio M, Tecchio C, Barison E, Benedetti F

Obter o texto integral

Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service Por Restelli U, Andreoni M, Antinori A, Bonfanti M, Di Perri G, Galli M, Lazzarin A, Rizzardini G, Croce D

Obter o texto integral

The Economic Impact of Loss to Follow-Up in Eosinophilic Esophagitis: A Model-Based Analysis from the Perspective of Italian National Health Service Por Bonfanti M, Fardella M, Morani M, Oliva S, Savarino EV, Giodice R, Saab JP, Castagnaro E, Tassone A, Restelli U

Obter o texto integral

Role of Inhaled Methoxyflurane in the Management of Acute Trauma Pain Por Fabbri A, Ruggiano G, Garcia Collado S, Ricard-Hibon A, Restelli U, Sbrana G, Marinangeli F, Farina A, Coffey F

Obter o texto integral

Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey [Corrigendum] Por Innocenti R, Rigacci L, Restelli U, Scappini B, Gianfaldoni G, Fanci R, Mannelli F, Scolari F, Croce D, Bonizzoni E, Perrone T, Bosi A

Obter o texto integral

Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey Por Innocenti R, Rigacci L, Restelli U, Scappini B, Gianfaldoni G, Fanci R, Mannelli F, Scolari F, Croce D, Bonizzoni E, Perrone T, Bosi A

Obter o texto integral

Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district Por Polilli E, Cento V, Restelli U, Ceccherini-Silberstein F, Aragri M, Di Maio VC, Sciacca A, Santoleri F, Fazii P, Costantini A, Perno CF, Parruti G

Obter o texto integral